HomeBusinessGlobal EconomyAstraZeneca’s CEO Is Willing to Compromise — When It’s for TrumpAstraZeneca’s CEO Is Willing to Compromise — When It’s for Trump November 5, 2025nileshsha@hotmail.com Pascal Soriot has turned the drugmaker into an oncology powerhouse with a high-pressure culture and a deep relationship with the US. www.bloomberg.com #AstraZenecas #CEO #Compromise #ampmdash #TrumpRelated reading:NY Commuter Rail Strikes, Stranding 300,000 Daily RidersUS Allows Russia Oil Sales Waiver to Expire Despite Tight MarketIndia Tightens Silver Import Rules Amid Measures to Defend RupeeShare: X · Facebook · LinkedIn
Wall Street Ends 2025 Grinning Despite Some GloomGet caught up. www.bloomberg.com #Wall #Street #Ends #2025Grinning #DespiteSome #Gloom Related reading:NY Commuter Rail Strikes, Stranding 300,000 Daily RidersUS Allows…
Setting the Odds for Congress Avoiding a ShutdownThis is Washington Edition, the newsletter about money, power and politics in the nation’s capital. Every Monday, Bloomberg Intelligence senior…
Amazon to Shut Down Wondery Podcast Studio, Reorganize Audio BusinessAs podcasting becomes video-oriented, Amazon is shuffling Wondery into Audible and a new “creator services” team while cutting approximately 110…